Screening of conventional anticonvulsants in a genetic mouse model of epilepsy.
about
Cacna1g is a genetic modifier of epilepsy in a mouse model of Dravet syndrome.The synthetic neuroactive steroid SGE-516 reduces seizure burden and improves survival in a Dravet syndrome mouse model.Ion Channels in Genetic Epilepsy: From Genes and Mechanisms to Disease-Targeted Therapies.Preclinical Animal Models for Dravet Syndrome: Seizure Phenotypes, Comorbidities and Drug Screening.Novel and de novo mutations in pediatric refractory epilepsy
P2860
Screening of conventional anticonvulsants in a genetic mouse model of epilepsy.
description
2017 nî lūn-bûn
@nan
2017 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Screening of conventional anticonvulsants in a genetic mouse model of epilepsy.
@ast
Screening of conventional anticonvulsants in a genetic mouse model of epilepsy.
@en
type
label
Screening of conventional anticonvulsants in a genetic mouse model of epilepsy.
@ast
Screening of conventional anticonvulsants in a genetic mouse model of epilepsy.
@en
prefLabel
Screening of conventional anticonvulsants in a genetic mouse model of epilepsy.
@ast
Screening of conventional anticonvulsants in a genetic mouse model of epilepsy.
@en
P2093
P2860
P356
P1476
Screening of conventional anticonvulsants in a genetic mouse model of epilepsy.
@en
P2093
Alfred L George
Jennifer A Kearney
Linda Laux
Lyndsey L Anderson
Nicole A Hawkins
Tracy S Gertler
P2860
P304
P356
10.1002/ACN3.413
P577
2017-04-26T00:00:00Z